Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, ...

Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different ...

During the quarter, Immutep was granted two new patents for LAG525 in in the Philippines and the United States. Immutep was ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...

Researchers have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors. The newly discovered cells counteract tumor development and may ...

A sarcoma is a cancer that arises from uncontrolled cell ... of sarcoma that can be classified into three broad groups: soft tissue sarcoma; primary bone sarcoma; and gastro-intestinal stromal ...

The FDA has granted clearance to an investigational new drug application for CLD-201 for solid tumor treatment, based on ...